Arcus Biosciences RCUS Total debt

Total debt at other companies

Bristol-Myers SquibbBMY

$43.33B-12.3%

Merck & Co.MRK

$56.73B+54.0%

Regeneron PharmaceuticalsREGN

$2.71B+0.1%

AbbVieABBV

$62.36B+1.8%

ImmunomeIMNM

$3.69M-22.6%

ImmunityBio, Inc.IBRX

$445.39M+32.2%

FAQ

What is Arcus Biosciences's total debt?

Arcus Biosciences (RCUS) reported total debt of $114M in Q2 2026.

How has Arcus Biosciences's total debt changed year-over-year?

Arcus Biosciences's total debt increased by 4.6% year-over-year, from $109M to $114M.

What is the long-term trend for Arcus Biosciences's total debt?

Over 5 years (2020 to 2025), Arcus Biosciences's total debt has grown at a 61.3% compound annual growth rate (CAGR), from $18.11M to $198M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.